Few antimicrobial drugs function by directly targeting RNA. A small molecule that binds the hepatitis C viral genome by 'locking' in a particular RNA conformation to inhibit viral protein production suggests a new paradigm for drug design.
References
World Health Organization. Hepatitis C Fact Sheet No. 164 (WHO, Geneva, 1999).
Seth, P.P. et al. J. Med. Chem. 48, 7099–7102 (2005).
Parsons, J. et al. Nat. Chem. Biol. 5, 823–825 (2009).
Pestova, T.V., Shatsky, I.N., Fletcher, S.P., Jackson, R.J. & Hellen, C.U. Genes Dev. 12, 67–83 (1998).
Kim, I., Lukavsky, P.J. & Puglisi, J.D. J. Am. Chem. Soc. 124, 9338–9339 (2002).
Spahn, C.M. et al. Science 291, 1959–1962 (2001).
Dibrov, S.M., Johnston-Cox, H., Weng, Y.H. & Hermann, T. Angew. Chem Int. Ed. Engl. 46, 226–229 (2007).
Leulliot, N. & Varani, G. Biochemistry 40, 7947–7956 (2001).
Williamson, J.R. Nat. Struct. Biol. 7, 834–837 (2000).
Winkler, W.C. & Breaker, R.R. Annu. Rev. Microbiol. 59, 487–517 (2005).
Zhang, Q., Stelzer, A.C., Fisher, C.K. & Al-Hashimi, H.M. Nature 450, 1263–1267 (2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Begley, D., Varani, G. Locking out viral replication. Nat Chem Biol 5, 782–783 (2009). https://doi.org/10.1038/nchembio.245
Issue Date:
DOI: https://doi.org/10.1038/nchembio.245
- Springer Nature America, Inc.